Experimental gene therapies for the NCLs
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE(2020)
摘要
The neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, are a group of rare monogenic neurodegenerative diseases predominantly affecting children. All NCLs are lethal and incurable and only one has an approved treatment available. To date, 13 NCL subtypes (CLN1-8, CLN10-14) have been identified, based on the particular disease-causing defective gene. The exact functions of NCL proteins and the pathological mechanisms underlying the diseases are still unclear. However, gene therapy has emerged as an attractive therapeutic strategy for this group of conditions. Here we provide a short review discussing updates on the current gene therapy studies for the NCLs.
更多查看译文
关键词
Neuronal ceroid lipofuscinoses,Batten disease,Gene therapy,Neurodegeneration,Pre-clinical studies,Clinical trials
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要